Octapharma, ASH

Octapharma to present new clinical and scientific data at ASH 2023 from ongoing research initiatives aimed at advancing care for people living with bleeding disorders

Published on 08/07/2025 at 18:04 | prnewswire.co.uk

Octapharma AG Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom

en | CA7609751028 | OCTAPHARMA | boerse | 67978556 |